Positives

• MS patients on this S1P modulator describe sharp reductions in relapse activity along with less brain volume loss on serial MRI, which several link to improved memory and processing speed Cleveland Clinic.
  
  
• A patient on the once-daily oral capsule reported being able to stay on therapy for years with only 3% of the trial cohort discontinuing for side effects, which she contrasted favorably with prior infusion drugs PMC.
  
  

Negatives

• Patients describe head colds, chest infections, and urinary tract infections as the most disruptive recurring side effects, sometimes requiring treatment pauses MS Society.
  
  
• A user reported transaminase elevations on routine bloodwork that triggered repeated dose interruptions and ultimately a switch to a different agent PMC.
  
  

Hurdles & Side Effects

• A new starter described the mandatory 7-day dose-titration pack and pre-treatment cardiac and ophthalmologic screening as a significant logistical lift before her first full dose Cleveland Clinic.
  
  
• A patient seeking it off-label for post-viral neuroinflammation found insurers refused coverage outside relapsing MS or ulcerative colitis indications Drugs.com.